Pinsent Masons claims a win for Neovasc on European heart valve patent case

28 Mar 2019 | 10:41 am | 1 min. read

International law firm Pinsent Masons has successfully advised Neovasc on the appeal case for the ownership battle over European mitral heart valve patent against Edwards Life Science unit CardiAQ.

Latest press releases

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons secures 11th place in Financial Times Diversity Leaders 2021 Report

Multinational law firm Pinsent Masons has been named as a top 20 Diversity Leader by the Financial Times, ranked 11th in its Diversity Leaders 2021 report.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Bodymed AG on the sale to Nestlé Health Science

The multinational law firm Pinsent Masons advises the holding company of the founder Dr Hardy Walle on the sale of all shares of Bodymed AG to Nestlé Health Science.

Pinsent Masons advises shareholders of Goodtill on its sale to SumUp

Multinational law firm Pinsent Masons has advised the shareholders of Goodtill on its sale to SumUp

Pinsent Masons rolls out the Mindful Business Charter in the Middle East to promote mental health and wellbeing

Pinsent Masons has rolled out its Mindful Business Charter across its business in the Middle East. It adopts and promotes a culture of openness about mental wellbeing and encourages working arrangements that will reduce the unnecessary causes of stress and pressure in the workplace thereby ensuring higher team performances.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts